Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign

See also
Status	Clinical Trial	Phase
Completed	`NCT02698137` - Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)
Completed	`NCT02261623` - Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry
Recruiting	`NCT01438385` - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders	N/A
Not yet recruiting	`NCT02465229` - Comparison of Diagnostic Accuracy Before or After Stricture Dilation in Biliary Stricture	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02698137 - Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)

Completed

NCT02261623 - Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry

Recruiting

NCT01438385 - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

N/A

Not yet recruiting

NCT02465229 - Comparison of Diagnostic Accuracy Before or After Stricture Dilation in Biliary Stricture

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01343160
Study type	Interventional
Source	W.L.Gore & Associates
Contact
Status	Completed
Phase	N/A
Start date	April 2011
Completion date	May 2015

Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms